Sustained long-term clinical efficacy and safety in patients with psoriasis for up to 2.5 years on etanercept

被引：0
|
作者：
Serban, Anca
Elewski, Boni
Leonardi, Craig
Gottlieb, Alice
Strober, Bruce
van der Kerkhof, Peter C. M.
Ortonne, Jean Paul
机构：
[1] Wyeth Ayerst Res, Collegeville, PA USA
[2] Univ Alabama, Birmingham, AL USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Johns Hopkins Univ, New York, NY USA
[6] Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands
[7] Hosp Archet, Nice, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
64
引用
收藏
页码：1813 / 1813
页数：1
相关论文
共 50 条
  • [31] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
  • [32] Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis
    Dijkmans, B.
    Sridharan, S.
    Fatenejad, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 187 - 187
  • [33] Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice
    Maria Fernandez-Torres, Rosa
    Paradela, Sabela
    Fonseca, Eduardo
    VALUE IN HEALTH, 2015, 18 (08) : 1158 - 1161
  • [34] Long-term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single-center experience
    Momose, Mami
    Asahina, Akihiko
    Umezawa, Yoshinori
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2018, 45 (03): : 318 - 321
  • [35] Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
    van de Kerkhof, PCM
    Berth-Jones, J
    Griffiths, CEM
    Harrison, PV
    Hönigsmann, H
    Marks, R
    Roelandts, R
    Schöpf, E
    Trompke, C
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) : 414 - 422
  • [36] Etanercept, childhood and long-term safety: a case of five years treatment
    Mazzotta, Annamaria
    Saraceno, Rosita
    Esposito, Maria
    Chimenti, Sergio
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (05) : 776 - 777
  • [37] Sustained efficacy of etanercept in ankylosing spondylitis for up to 2 years
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, J
    Clegg, DO
    Inman, RD
    Kivitz, A
    Zhou, L
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 336 - 336
  • [38] Long-term safety of ustekinumab in patients with moderate to severe psoriasis through up to 5 years of continuous follow-up
    Papp, Kim
    Reich, Kristian
    Lebwohl, Mark
    Szapary, Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB205 - AB205
  • [39] Long term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Papp, K.
    Kimball, A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K.
    JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 240
  • [40] Long-term efficacy and safety of galantamine in patients with Alzheimer's disease treated for up to 4 years
    Burns, A
    Pirttila, T
    Gold, M
    Schwalen, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S382 - S382
12345